Liquid purification or separation – With alarm – indicator – register – recorder – signal or...
Reexamination Certificate
2004-10-11
2010-06-15
Savage, Matthew O (Department: 1797)
Liquid purification or separation
With alarm, indicator, register, recorder, signal or...
C210S192000, C210S205000, C210S249000, C210S416100, C422S045000, C422S119000, C422S186070, C422S181000, C422S198000, C261S112100, C261SDIG042
Reexamination Certificate
active
07736494
ABSTRACT:
An ozone delivery system for delivering and manufacturing a measured amount of an ozone/oxygen admixture, which is able to measure, control, report and differentiate between delivered-ozone and absorbed-dose of ozone. Improved gas-fluid contacting devices that maximize gas-fluid mass transfer may be included. All gas contacting surfaces of the system, including one or more gas-fluid contacting devices are made from ozone-inert construction materials that generally do not absorb ozone or introduce amounts of contaminants or deleterious byproducts of oxidation into a fluid or non-fluid target from ozone oxidation.
REFERENCES:
patent: 2865617 (1958-12-01), Dickens et al.
patent: 4632980 (1986-12-01), Zee et al.
patent: 5052382 (1991-10-01), Wainwright
patent: 5126376 (1992-06-01), Herman
patent: 5185371 (1993-02-01), Rubinstein
patent: 5190977 (1993-03-01), Herman
patent: 5211912 (1993-05-01), Rubinstein
patent: 5260342 (1993-11-01), Herman
patent: 5270344 (1993-12-01), Herman
patent: 5281392 (1994-01-01), Rubinstein
patent: 5364879 (1994-11-01), Herman
patent: 5540898 (1996-07-01), Davidson
patent: 5591457 (1997-01-01), Bolton
patent: 5834030 (1998-11-01), Bolton
patent: 5882591 (1999-03-01), Kekez
patent: 6027688 (2000-02-01), Wainwright
patent: 6060020 (2000-05-01), Piuk et al.
patent: 6204058 (2001-03-01), Bolton
patent: 6303152 (2001-10-01), Kief
patent: 6399664 (2002-06-01), Smith
patent: 6569467 (2003-05-01), Bolton
patent: 2003/0118473 (2003-06-01), Sunnen
patent: 1269935 (1986-04-01), None
patent: WO 96/17635 (1996-06-01), None
Alter, Harvey J, MD, “G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus,” Transfusion, vol. 37, pp. 569-572 (Jun. 1997).
Bailey, P., et al., “Complexes and Radicals Produced During Ozonation of Olefins”, Ozone Reactions with Organic Compounds, pp. 1-8 (May 1971).
Begin, M.E., et al., Selective Killing of Human Cancer Cells by Polyunsaturated Fatty Acids, Prostaglandins Leukotrienes and Medicine, 19:177-86 (1985).
Begin, M.E., et al., Selected Fatty Acids as Possible Itermediates for Selective Cytotoxic Activity of Anticancer Agents Involving Oxygen Radicals, Anticancer Research, 6:291-96 (1985).
Begin, M.E., et al.,Polyunsaturated Fatty Acid-Induced Cytotoxicity Against Tumor Cells and its Relationship to Lipid Peroxidation, J. Nat'l. Cancer Inst., vol. 80, No. 3, pp. 188-194 (Apr. 1988).
Bird, R.P., et al., Comparative Studies on Different Methods of Malonaldehyde Determination, Methods in Enzymology, vol. 105, pp. 299-305 (1984).
Bird, R.P., et al., Determination of Malonaldehyde in Biological materials by High Pressure Liquid Chromatography, Analytical Biochemistry, 128: 240-44 (1983).
Blajchman, M., et al., Bacteria in the Blood Supply: An Overlooked Issue in Transfusion Medicine, Blood Safety: Current Challenges, S.J. Nance ed., pp. 213-28 (1992).
Bocci, V., et al., Studies of the Biological Effects of Ozone 1. Induction of Interferon γ on Human Leucocytes, Haematologica vol. 75, pp. 510-515 (1990).
Bocci, V., et al., Studies on the Biological Effects of Ozone: 2. Induction of Tumor Necrosis Factor (TNF-α) on Human Leucocytes, Lymphokine & Cytokine, vol. 10, No. 5, pp. 409-412 (1991).
Bocci, V., et al., Studies of the Biological Effects of Ozone 3, An Attempt to Define Conditions for Optimal Induction of Cytokines, Lymphokine & Cytokine Research, vol. 12, No. 2, pp. 121-126 (1993).
Bocci, V., et al., Studies of the Biological Effects of Ozone 4, Cytokine Production and Glutathione Levels in Human Erythrocytes, J. Biological Regulators and Homeostatic Agents, vol. 7, No. 4, pp. 133-138 (1993).
Bocci, V., et al., A Reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy), How ‘Inflammatory’ Cytokines May Have a Therapeutic Role, Mediators of Inflammation, vol. 3, pp. 315-321, 1994.
Bocci, V., et al., Studies on the Biological Effects of Ozone 7, Generation of Reactive Oxygen Species (ROS) After Exposure of Human Blood to Ozone, Journal Biological Regulators and Homeostatic Agents, vol. 12, No. 3, pp. 67-75 (1998).
Bocci, V., et al., Studies on the Biological Effects of Ozone 8, Effects on the Total Antioxidant Status and on Interleukin-8 Production, Mediators of Inflammation, vol. 7, pp. 313-317 (1998).
Bocci, V., et al., Studies on the Biological Effects of Ozone 9, Effects of Ozone on Human Platelets, Platelet, vol. 10, pp. 110-116 (1999).
Bocci, V., et al., Studies on the Biological Effects of Ozone 10, Release of Factors from Ozonated Human Platelets, Mediators of Inflammation, vol. 8, pp. 205-209 (1999).
Bolton, et al., The Biological Effects of Ozone on Reprsentative Memb ers of Five Groups of Animal Viruses, Environmental Research, vol. 27, pp. 476-484 (1982).
Bowden, R., Cytomegalovirus: Transmission by Blood Components and Measures of Prevention, Blood Safety: Current Challenges, S.J. Nance ed., pp. 201-211 (1992).
Carpendale, M.T.F., et al., Ozone Inactivates HIV at Noncytotoxic Concentrations, Antiviral Research, vol. 16, 1919, pp. 281-292 (1991).
Carrasco, L. The Inhibition of Cell Functions After Viral Infection, FEBS Letters, vol. 76 No. 1, pp. 11-15, (1977).
Carrasco, L., Selective Inhibition of Translation in Transformed Cells FEBS Letters, vol. 110, No. 2, pp. 341-343, (1980).
Chiu, E.K.W., et al., A Prospective Study of Symptomatic Baceteremia Following Platelet Transfusions and of its Management, Transfusion, vol. 34, No. 11, pp. 950-954 (1994).
Corongiu, F.B., et al., An Improved and Simple Method for Determining Diene Conjugation in Autoxidized Polyunsaturated Fatty Acids, Chem.-Biol. Interactions, vol. 44, pp. 289-297 (1983).
Criegee, R., et al., Fragmentation of Ozonides by Solvents, Ozone Reactions with Organic Compounds, Advances in Chemistry, Series 112, pp. 23-24 (1972).
Cross, C.E. et al., FEBS Letters, vol. 298, No. 2, 3, pp. 269-272 (1992).
Cruse and Lewis, Illustrated Dictionary of Immunology, 1995, pp. 168-172.
Dodd, R., Adverse Consequences of Blood Transfusion: Quantitative Risk Estimates, Blood Supply: Rises, Perceptions and Prospects for the Future, S.J. Nance, ed., p. 1-24 (1994).
Easterbauer, H., et al., Chemistry and Biochemistry of 4-Hydroxynonenal, Malonaldehyde and Related Aldehydes; Free Radical Biology & Medicine, vol. 11, pp. 81-128 (1991).
Fletcher, B.L., et al., Measurement of Fluorescent Lipid Peroxidation Products in Biological Systems and Tissues, Analytical Biochemistry, vol. 52, pp. 1-9 (1973).
Garber, G.E., et al., The Use of Ozone-Treated Blood in the Therapy of HIV Infection and Immune Disease: A Pilot Study of Safety and Efficacy, AIDS, vol. 5, pp. 981-984 (1991).
Gregory, S.H., et al., The Role of Colony-Stimulating Factors in Host Defenses, Society for Experimental Biology and Medicine, pp. 349-360 (1991).
Hicks, M., et al., A Spectrophotometric Method for the Determination of Lipid Hydroxyperoxides, Analytical Biochemistry 99, pp. 249-253 (1979).
Hudlickey, T., McGraw-Hill Encyclopedia of Chemistry, Fifth Edition, 1982, pp. 1034-1038.
Lackritz, E.M., et al., Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States, The New England Journal of Medicine, vol. 333, No. 26, pp. 1721-1725, (1995).
Larini, A., et al., The Ozone Tolerance: I) Enhancement of Antioxidant Enzymes is Ozone Dose-dependent in Jurkat Cells, Free Radical Research, vol. 37, No. 11, pp. 1163-1168 (Nov. 2003).
Larini, A., et al., Effect of 4-hydroxynonenal on Antioxidant Capacity and Apoptosis Induction in Jurkat T Cells, Free Radical Research, vol. 38, No. 5, pp. 509-516 (May 2004).
Morrow, J. et al., Septic Reactions to Platelet Transfusion: A Persistent Problem, JAMA, vol. 266, No., pp. 555-558 (1991).
Ogawa, M., Differentiation and Proliferation of Hematopoietic Stem Cells, Blood, vol. 81, No. 11, pp. 2844-2853 (1993).
Oxford Biomedical Research, Colorimetric Assay for Lipid Peroxidation, Product No. FR 12, revised Sep. 2003.
Pryor, W.A., et al., Chemical Methods for the Detection of Lipid Hydr
Keyser Steven A.
Latino Joseph S.
AcquiSci, Inc.
Morriss O'Bryant Compagni
Savage Matthew O
LandOfFree
Ozone delivery system including a variable pitch gas-fluid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ozone delivery system including a variable pitch gas-fluid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ozone delivery system including a variable pitch gas-fluid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4223738